Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D002439:Cefotaxime / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D002443:Ceftriaxone; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development; D004927:Escherichia coli Infections / Q000188:drug therapy*; D007700:Kinetics; D051379:Mice; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000254:growth & development; D013982:Ticarcillin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D013982:Ticarcillin; D002439:Cefotaxime